Nephrocare Q1 Results: Audio of Q1FY27 earnings call released

Nephrocare Health Services Limited has uploaded the audio recording of its investors' conference call regarding the first quarter of FY27 financial results. The session took place on August 12, 2026, and addressed the unaudited standalone and consolidated performance for the period ended June 30, 2026.

The disclosure was made in compliance with Regulation 30, Regulation 46(2), and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Call Details

The audio recording is accessible via the company's official website at www.nephroplus.com . This release serves as a continuation of the earlier communication dated July 24, 2026, which likely contained the written financial statements or a notice regarding the upcoming discussion.

Kishore Kathri, Company Secretary and Head Legal at Nephrocare, signed the disclosure letter. The document confirms that the recording is available for public record, ensuring transparency for investors and analysts reviewing the quarterly performance.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.65%	-4.77%	+5.97%	+16.70%	+44.12%	+44.12%

nephrocare health services has reaffirmed its medium-term growth guidance, confirming an expected growth range of 15% to 20% over the coming 3 to 5 years. The company's confirmation of this outlook underscores its stated confidence in the sustainability of its business performance over the stated period.

Growth Guidance Overview

The key parameters of the company's confirmed medium-term growth prediction are outlined below:

Parameter:	Details
Growth Guidance Range:	15% to 20%
Guidance Horizon:	3 to 5 years

Nephrocare Health Services' reaffirmation of this growth range provides stakeholders with a stated directional view of the company's expected performance trajectory over the medium term. The guidance covers a multi-year horizon, reflecting the company's assessment of its business outlook as communicated in its latest update.

Key Highlights

Growth range confirmed: 15% to 20%
Time horizon: Coming 3 to 5 years
The company has formally confirmed this as its expected medium-term growth prediction

No additional financial figures, quarterly results, or operational metrics were provided alongside this guidance confirmation.